Radnostix (INIS) Common Equity (2010 - 2026)
Radnostix (INIS) posted Common Equity of $1.89 million for Q2 2026, down 55.6% from $4.27 million a year earlier and down 28.5% from the prior quarter.
Powered by 
Analysis
Radnostix (INIS) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, Radnostix's Common Equity came in at $3.69 million, down 15.1% from FY2024.
- Annual Common Equity shows a five-year compound annual growth rate of 5.0% (FY2020 to FY2025).
- In prior years, Radnostix's Common Equity was $4.35 million in FY2024 (+7.7%), $4.04 million in FY2023 (-7.0%), $4.34 million in FY2022 (+59.0%) and $2.73 million in FY2021 (-5.4%).
- The Q2 2026 figure stands as the lowest quarterly Common Equity since Q3 2020.
- On a year-over-year basis, Common Equity has declined in each of the last three quarters, with an average decline of 10.3% over the last eight quarters.
- The strongest year-over-year quarter for Common Equity in the past five years was Q3 2021, with growth of 274.8%; the weakest was Q2 2026, with a decline of 55.6%.
- According to Business Quant data, Common Equity for the three prior quarters was $2.65 million (Q1 2026), $3.69 million (Q4 2025) and $4.1 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 51.81 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 89.30 Bn |
| 10 | Radnostix | 20.37 Mn | 14.48 Mn | 1.36 Mn | 1.89 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.89 Mn |
| Mar 31, 2026 | 2.65 Mn |
| Dec 31, 2025 | 3.69 Mn |
| Sep 30, 2025 | 4.10 Mn |
| Jun 30, 2025 | 4.27 Mn |
| Mar 31, 2025 | 4.34 Mn |
| Dec 31, 2024 | 4.35 Mn |
| Sep 30, 2024 | 4.04 Mn |
| Jun 30, 2024 | 3.83 Mn |
| Mar 31, 2024 | 4.04 Mn |
| Dec 31, 2023 | 4.04 Mn |
| Sep 30, 2023 | 4.08 Mn |
| Jun 30, 2023 | 4.25 Mn |
| Mar 31, 2023 | 4.45 Mn |
| Dec 31, 2022 | 4.34 Mn |
| Sep 30, 2022 | 4.40 Mn |
| Jun 30, 2022 | 4.90 Mn |
| Mar 31, 2022 | 4.44 Mn |
| Dec 31, 2021 | 2.73 Mn |
| Sep 30, 2021 | 2.68 Mn |
API Access
Radnostix Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=INIS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "INIS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=INIS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();